Biomerica Reports First Quarter Fiscal 2027 Financial Results
Globe Newswire•16/10/2026•08:19 ET
0
Key Highlights
- ➤Medicare-related test orders rose 120% to 22 in September 2026 from August
- ➤100% of initial valid Medicare claims paid at full $300 CMS rate
- ➤Net sales fell to $1.3 million from $1.4 million year over year
- ➤Net loss reached $1.2 million, or $0.37 per share
- ➤B. Riley Securities engaged to evaluate partnerships and business combinations
* InFoods® IBS Commercial Progress: Medicare-related test orders increased 120% in September 2026 compared to August, with growing physician participation and repeat ordering activity
* InFoods® IBS update: 100% of all initial valid Medicare claims processed as of October 15, 2026 have been paid at the full CMS payment rate of $300
Get started
Create a free account to read the full story.